SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-024693
Filing Date
2011-04-19
Accepted
2011-04-19 19:35:42
Documents
1
Period of Report
2011-04-19

Document Format Files

Seq Description Document Type Size
1 rrd308582.html 3  
1 rrd308582.xml 3 3302
  Complete submission text file 0001181431-11-024693.txt   4742
Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
Behrens Mary Taylor (Reporting) CIK: 0001309855 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35144 | Film No.: 11769232

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Holding Co. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
SIC: 2834 Pharmaceutical Preparations